FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY
Clinical trials for FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY explained in plain language.
Never miss a new study
Get alerted when new FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY trials appear
Sign up with your email to follow new studies for FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug GL-0719 enters first human trials for rare blood disorder
Disease control Recruiting nowThis early-stage trial tests a new drug called GL-0719 in healthy volunteers and people with cold agglutinin disease, a rare condition where cold temperatures cause the immune system to destroy red blood cells. The study aims to check safety, how the drug moves through the body, …
Matched conditions: FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY
Phase: PHASE1 • Sponsor: Gliknik Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can a new injectable drug safely tackle weight? an early trial seeks answers
Knowledge-focused Recruiting nowThis early-stage trial is testing whether an experimental drug called ZP6590 is safe and how the body processes it. The study includes men with normal weight, overweight, and obesity. Some participants receive a single dose of ZP6590 or a placebo, while others receive multiple do…
Matched conditions: FIRST IN MAN STUDY TO EVALUATE INITIAL SAFETY
Phase: EARLY_PHASE1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC